Patents by Inventor Kanamata Reddy

Kanamata Reddy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic compounds
    Patent number: 10487054
    Abstract: The invention provides a compound of formula I: or a salt thereof, wherein R1, R2, R3, R4 and ring A have any of the values described in the specification, as well as compositions comprising a compound of formula I. The compounds are useful as anti-cancer agents.
    Type: Grant
    Filed: April 20, 2018
    Date of Patent: November 26, 2019
    Assignee: Regents of the University of Minnesota
    Inventors: Zigang Dong, Ann M. Bode, Kanamata Reddy
  • THERAPEUTIC COMPOUNDS
    Publication number: 20180339966
    Abstract: The invention provides a compound of formula I: or a salt thereof, wherein R1, R2, R3, R4 and ring A have any of the values described in the specification, as well as compositions comprising a compound of formula I. The compounds are useful as anti-cancer agents.
    Type: Application
    Filed: April 20, 2018
    Publication date: November 29, 2018
    Inventors: Zigang Dong, Ann M. Bode, Kanamata Reddy
  • Aurora kinase inhibitors
    Patent number: 9796671
    Abstract: The invention provides compounds of the formula: and salts thereof that are useful as intermediates for preparing corresponding compounds of formula I: that are useful for treating conditions associated with Aurora B kinase activity (e.g. cancer).
    Type: Grant
    Filed: February 29, 2016
    Date of Patent: October 24, 2017
    Assignee: REGENTS OF THE UNIVERSITY OF MINNESOTA
    Inventors: Ann M. Bode, Zigang Dong, Kanamata Reddy
  • Inhibitors of beta-catenin in treatment of colorectal cancer
    Patent number: 9616047
    Abstract: Compounds are disclosed which are effective for inhibiting ?-catenin or disrupting a ?-catenin/Tcf-4 complex, and for causing effective attenuation of colon carcinogenesis. The compounds may be effective treatment for colorectal cancer (CRC) when administered in an effective dose to a patient afflicted therewith.
    Type: Grant
    Filed: June 30, 2015
    Date of Patent: April 11, 2017
    Assignee: Regents of University of Minnesota
    Inventors: Ann Marie Bode, Zigang Dong, Srinivasa Reddy Kanamata Reddy
  • AURORA KINASE INHIBITORS
    Publication number: 20160176820
    Abstract: The invention provides compounds of the formula: and salts thereof that are useful as intermediates for preparing corresponding compounds of formula I: that are useful for treating conditions associated with Aurora B kinase activity (e.g. cancer).
    Type: Application
    Filed: February 29, 2016
    Publication date: June 23, 2016
    Applicant: REGENTS OF THE UNIVERSITY OF MINNESOTA
    Inventors: Ann M. Bode, Zigang Dong, Kanamata Reddy
  • Aurora kinase inhibitors
    Patent number: 9296730
    Abstract: The invention provides a compound of formula I: or a salt thereof, wherein ring A and R1-R4 have any of the values defined in the specification. The compounds have activity as Aurora B kinase inhibitors and are useful for treating conditions associated with Aurora B kinase activity (e.g. cancer).
    Type: Grant
    Filed: October 25, 2013
    Date of Patent: March 29, 2016
    Assignee: Regents of the University of Minnesota
    Inventors: Ann M. Bode, Zigang Dong, Kanamata Reddy
  • INHIBITORS OF BETA-CATENIN IN TREATMENT OF COLORECTAL CANCER
    Publication number: 20150374662
    Abstract: Compounds are disclosed which are effective for inhibiting ?-catenin or disrupting a ?-catenin/Tcf-4 complex, and for causing effective attenuation of colon carcinogenesis. The compounds may be effective treatment for colorectal cancer (CRC) when administered in an effective dose to a patient afflicted therewith.
    Type: Application
    Filed: June 30, 2015
    Publication date: December 31, 2015
    Inventors: Ann Marie Bode, Zigang Dong, Srinivasa Reddy Kanamata Reddy
  • AURORA KINASE INHIBITORS
    Publication number: 20150232456
    Abstract: The invention provides a compound of formula I: or a salt thereof, wherein ring A and R1-R4 have any of the values defined in the specification. The compounds have activity as Aurora B kinase inhibitors and are useful for treating conditions associated with Aurora B kinase activity (e.g. cancer).
    Type: Application
    Filed: October 25, 2013
    Publication date: August 20, 2015
    Applicant: REGENTS OF THE UNIVERSITY OF MINNESOTA
    Inventors: Ann M. Bode, Zigang Dong, Kanamata Reddy